Insights
Florida’s New Tort Reform Package: Changes Affect Admissibility of Evidence and Calculation of Medical Damages
March 23, 2023
A major legislative package, House Bill 837 (companion to Senate Bill 236) was signed into law by Florida Governor Ron DeSantis on March 24, 2023, and will consummate tort reform in Florida. The package introduces significant changes to how lawsuits are filed and litigated in Florida, and seeks to bring balance and transparency to tort litigation. The bill becomes effective immediately, and will be applied prospectively.
Altogether, HB 837 makes multiple substantive changes to Florida’s civil justice system. For purposes of this article, we focus solely on how the bill provides for transparency in damages by providing uniform standards to aid juries in calculating the accurate value of medical damages in personal injury or wrongful death actions.
Restrictions on the Admissibility of Past and Future Medical Bills as Evidence at Trial
HB 837’s language notably modifies the collateral source rule to limit the introduction of evidence for medical damages at trial. Evidence offered to prove the amount of damages for past or future medical treatment at trial generally will be limited to evidence of the amount actually paid.
Past Medical Care
First, the bill limits evidence of past paid medical bills to the amount actually paid for the services regardless of the source of the payment. Therefore, if a full medical bill for past services has been paid by an insurer, the actual amount paid by the insurer is the only amount admissible at trial. The initial billed amount presented by the provider may not be presented as evidence.
Second, the bill hinges on the admissibility of evidence to prove the amount of past unpaid medical bills on the type of health care coverage provided to a plaintiff.
Future Medical Bills
The bill also provides guidance on the admissibility of evidence relating to damages for future medical care.
Amount of Damages Recoverable at Trial
The bill prohibits damages from including any inflated amounts above the amount actually paid for the services provided to a plaintiff by a health care provider. Moreover, the bill forbids an award of damages from exceeding the amount:
Letters of Protection Disclosure
The bill provides for a mandated procedure in relation to the use of a letter of protection. If a plaintiff receives care pursuant to a letter of protection, the bill mandates that the plaintiff disclose:
To this end, the bill amends section 90.502(4), Florida Statutes, to declare that there exists no lawyer-client privilege in communications related to an attorney’s referral of a client for treatment. Notably, this provision would overturn the Florida Supreme Court’s 4–3 decision in Worley v. Central Florida YMCA, which found that “the defense could not seek discovery information about the relationship between plaintiff attorneys and medical providers to whom they referred clients, finding that was protected by attorney-client privilege.”
Looking Ahead
Under HB 837, the amount of damages that may be awarded to a plaintiff at trial will be limited to the actual costs of medical treatment as opposed to inflated or arbitrary charges. This bill, in turn, may lower tort costs by reducing a plaintiff’s recovery in certain cases and is expected to have a positive fiscal impact on private entities and state and local governments. As a downstream effect, the bill may serve to indirectly lower the cost for insurance products and medical services in Florida.
HB837 also will allow defendants to tell the jury whether the plaintiff’s attorneys referred their clients to a certain doctor and what that doctor’s relationship is with a plaintiff’s attorney. The bill is clearly designed to reverse past case law that kept the plaintiff’s attorney’s dealings with certain medical providers safe from discovery and hidden from the jury. This shift levels the playing field for defendants whose relationship with compulsory medical exam (CME) physicians is subject to discovery by plaintiff’s attorneys and disclosure to the jury.”